Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29395863

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Mar
First author
Giaccone G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Mar;19(3):274-275. doi: 10.1016/S1470-2045(18)30064-0.
    note
    Source null
    related pmid
    29395865
    relationship
    Comment in

Authors and identifiers

  1. name
    Giaccone G
    type
    Author
  2. name
    Kim C
    type
    Author
  3. name
    Thompson J
    type
    Author
  4. name
    McGuire C
    type
    Author
  5. name
    Kallakury B
    type
    Author
  6. name
    Chahine JJ
    type
    Author
  7. name
    Manning M
    type
    Author
  8. name
    Mogg R
    type
    Author
  9. name
    Blumenschein WM
    type
    Author
  10. name
    Tan MT
    type
    Author
  11. name
    Subramaniam DS
    type
    Author
  12. name
    Liu SV
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Giaccone G
    type
    Author
  2. name
    Kim C
    type
    Author
  3. name
    Thompson J
    type
    Author
  4. name
    McGuire C
    type
    Author
  5. name
    Kallakury B
    type
    Author
  6. name
    Chahine JJ
    type
    Author
  7. name
    Manning M
    type
    Author
  8. name
    Mogg R
    type
    Author
  9. name
    Blumenschein WM
    type
    Author
  10. name
    Tan MT
    type
    Author
  11. name
    Subramaniam DS
    type
    Author
  12. name
    Liu SV
    type
    Author
bibliography ids
  1. nci-bib-aa36054e1ceec3a2a091eaf9
book metadata
content sha256
4f8b214b89c9ad7a8d1a7193515b44d95f4e04fc4b14b248e70e5e32d017be00
document type
citation
dois
  1. 10.1016/S1470-2045(18)30062-7
electronic publication date
display
2018 Jan 26
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29395863
immutable id
pubmed:29395863@4f8b214b89c9ad7a8d1a7193515b44d95f4e04fc4b14b248e70e5e32d017be00
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
347-355
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Mar;19(3):274-275. doi: 10.1016/S1470-2045(18)30064-0.
    note
    Source null
    related pmid
    29395865
    relationship
    Comment in
outcomes validated
false
pmid
29395863
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
08c3ba93c127eb3616f4184cab503abb5c8c53b70bed048ad9eea3604f8921d9
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Mar
precision
month
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29395863/
title
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.

Preserved source evidence · Not medical advice